Dupilumab treatment for atopic dermatitis is associated with decreased utilization of psychostimulants for attention deficit hyperactivity disorder: A retrospective cohort study

J Am Acad Dermatol. 2023 Apr;88(4):956-958. doi: 10.1016/j.jaad.2023.01.025. Epub 2023 Feb 1.
No abstract available

Keywords: ADD; ADHD; atopic dermatitis; dupilumab; dupixent; epidemiology; nootropic; psychostimulant.

MeSH terms

  • Attention Deficit Disorder with Hyperactivity* / complications
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Central Nervous System Stimulants* / therapeutic use
  • Dermatitis, Atopic* / complications
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Retrospective Studies
  • Treatment Outcome

Substances

  • dupilumab
  • Central Nervous System Stimulants